Voyager Therapeutics (VYGR) EPS (Diluted) Growth (1y) (2019 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) EPS (Diluted) Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 38.64% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 68.53% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 162.14% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -102.51% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 505.52% |
| 10 | Voyager Therapeutics | 215.07 Mn | 98.73 Mn | - | 28.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.97% |
| Mar 31, 2026 | 11.68% |
| Dec 31, 2025 | 93.69% |
| Sep 30, 2025 | -203.41% |
| Jun 30, 2025 | -223.88% |
| Mar 31, 2025 | -168.01% |
| Dec 31, 2024 | -147.26% |
| Sep 30, 2024 | 73.52% |
| Jun 30, 2024 | 65.57% |
| Mar 31, 2024 | -106.74% |
| Dec 31, 2023 | 305.43% |
| Sep 30, 2023 | -232.58% |
| Jun 30, 2023 | -2.39% |
| Mar 31, 2023 | 625.10% |
| Dec 31, 2022 | -506.42% |
| Sep 30, 2022 | 166.94% |
| Jun 30, 2022 | 34.48% |
| Mar 31, 2022 | 17.85% |
| Dec 31, 2021 | 135.54% |
| Sep 30, 2021 | -129.28% |